Skip to content

A study to evaluate the postprandial, short term effects of two baby nutrition products in adult, male volunteers

A study to evaluate the postprandial, short term effects of two baby nutrition products in adult, male volunteers - Postprandial effects of baby nutrition products

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40343
Enrollment
30
Registered
2014-02-19
Start date
2014-02-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increased triglyceride concentrations

Interventions

Subjects will be provided with two different milk powders dissolved in 400 mL water. These products are available in the supermarket or produced by Nutricia Research, and they are safe for human con

Sponsors

Nutricia
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Healthy, adult, male, Caucasian, Dutch-speaking subjects - Non-smokers - Lactose- and milk-tolerant - Age 18-25 yr - Body Mass Index (BMI) of 20-25 kg/m2 - Girth width

Exclusion criteria

Exclusion criteria: - Top sports men or athletes with a daily strenuous training program (>2 hr) - Known diseases or malfunctions e.g. fat malabsorption, gastrointestinal malformations, haemophilia, hepatitis B, human immunodeficiency virus (HIV), high blood-pressure, hyperlipidaemia or diabetes - Current illnesses which could interfere with the study (e.g. prolonged severe diarrhoea, regurgitation, severe flu): to be determined on judgement of the investigator - Medication use (except for paracetamol) or a medically prescribed diet - More than 21 alcoholic consumptions per week - Use of vitamin supplements, fish oil capsules or products rich in plant stanol or sterol esters during the study and 2 weeks in advance of study start - Any current participation, or participation within 8 weeks before study start, in any other study involving investigational or marketed products - Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements and instructions

Design outcomes

Primary

MeasureTime frame
Plasma triglyceride concentrations

Secondary

MeasureTime frame
Concentrations of free fatty acids, lipoproteins, glucose, insuline, amino acids and satiety hormones.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)